Molbio Diagnostics Surges 9% as Jefferies Names It a High-Conviction Top Pick
Molbio Diagnostics shares rallied sharply after Jefferies initiated coverage with a Buy rating and a rare “high-conviction top pick” call, citing substantial upside from current levels. The brokerage set a target price of Rs 1,600, implying about 27% upside from Tuesday’s close and nearly 98% above the company’s Rs 807 IPO price, reinforcing investor interest in the recently listed diagnostics stock.
